Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Venus Concept Inc (VERO)

Venus Concept Inc (VERO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Insider Sale: Director at $VERO (VERO) Sells 42,768 Shares

Anthony Natale, a director at $VERO ($VERO), sold 42,768 shares of the company on 12-03-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares....

VERO : 0.3040 (-0.16%)
Venus Concept: Q3 Earnings Snapshot

Venus Concept: Q3 Earnings Snapshot

VERO : 0.3040 (-0.16%)
Venus Concept Announces Third Quarter of Fiscal Year 2024 Financial Results

VERO : 0.3040 (-0.16%)
Venus Concept Announces Expansion of International Distribution Network and Certification of Products in India

VERO : 0.3040 (-0.16%)
Venus Concept Gains

Shares in Venus Concept Inc. (NASDAQ: VERO) moved higher Friday. The global medical aesthetic technology ...

VERO : 0.3040 (-0.16%)
VERO Stock Likely to Get Support From New Regulatory Nod in Australia

Venus Concept VERO, a leader in medical aesthetic technology, is set to strengthen its international presence following the regulatory clearance from Australia’s Therapeutic Goods Administration (TGA)...

AXGN : 14.91 (+1.64%)
KIDS : 23.17 (+0.30%)
TMDX : 68.26 (+3.03%)
VERO : 0.3040 (-0.16%)
Venus Concept: Q2 Earnings Snapshot

Venus Concept: Q2 Earnings Snapshot

VERO : 0.3040 (-0.16%)
Venus Concept to Release Second Quarter of Fiscal Year 2022 Financial Results on August 12, 2022

TORONTO, June 30, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...

VERO : 0.3040 (-0.16%)
Venus Concept Announces First Quarter of Fiscal Year 2022 Financial Results; Reaffirms Fiscal Year 2022 Revenue Guidance

TORONTO, May 12, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...

VERO : 0.3040 (-0.16%)
Venus Concept Receives New FDA 510(k) Clearance for Venus BlissMAX

Clearance Expands Indications for Use to Include Non-Invasive Lipolysis of the Back and Thighs and Increases Maximum Energy Output to 150 Watts...

VERO : 0.3040 (-0.16%)

Barchart Exclusives

Snowflake's Value is in the Clouds - Worth 26% More Based on its Strong FCF
Snowflake Inc. produced strong free cash flow in Q3, and its guidance allows analysts to forecast a Q4 44% FCF margin. Using its historical 1.5% FCF yield metric SNOW stock could be worth over 26% more at $232 per share. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar